squaric acid dibutyl ester has been researched along with Alopecia Circumscripta in 80 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 28 (35.00) | 18.7374 |
1990's | 22 (27.50) | 18.2507 |
2000's | 16 (20.00) | 29.6817 |
2010's | 10 (12.50) | 24.3611 |
2020's | 4 (5.00) | 2.80 |
Authors | Studies |
---|---|
Losol, E; Şentürk, N | 1 |
Hide, M; Numata, T; Takahagi, S; Tanaka, A | 1 |
Alessandrini, A; Bruni, F; Carpanese, MA; Misciali, C; Piraccini, BM; Sechi, A; Starace, M; Vezzoni, R | 1 |
Kim, BJ; Lee, S; Lee, WS; Lee, YB | 1 |
Gómez-Flores, M; Herz-Ruelas, ME; Lozano-Peña, AK; Ocampo-Candiani, J; Vázquez-Martínez, O; Welsh-Lozano, O | 1 |
Shapiro, J | 2 |
Adachi, T; Ebihara, T; Ohyama, M; Ouchi, T | 1 |
Avitabile, S; Cavani, A; Colonna, L; De Luca, A; Garcovich, S; Mazzanti, C; Nasorri, F; Sordi, D | 1 |
Kroshinsky, D; Vedak, P | 1 |
Furukawa, F; Yoshimasu, T | 1 |
Angelo, C; Calabresi, V; Castiglia, D; De Luca, N; Di Zenzo, G; Guerra, L; Pacifico, V; Zambruno, G | 1 |
Carlberg, V; Chen, CA; Kroshinsky, D | 1 |
Inui, S; Itami, S; Nakajima, T; Toda, N | 1 |
Burkhart, CN; Morrell, DS; Mukherjee, N | 1 |
Freyschmidt-Paul, P; Mueller, U; Singh, V; Zöller, M | 1 |
Ito, T; Tokura, Y | 1 |
Kishi, T; Miyachi, Y; Morita, K; Nagamachi, M; Nakamura, M | 1 |
Chin Giam, Y; Goh, CL; Tan, E; Tay, YK | 1 |
Misciali, C; Piraccini, BM; Tosti, A; Vincenzi, C | 1 |
Freyschmidt-Paul, P; Hoffmann, R; Hummel, S; McElwee, KJ; Vitacolonna, M; Zöller, M | 1 |
Henderson, RL; McMichael, AJ | 1 |
Dall'oglio, F; La Torre, G; Micali, G; Musumeci, ML; Nasca, MR; Potenza, C; Ricciardi, G | 1 |
Sawamura, D; Shibaki, A; Shimizu, H; Ujiie, H | 1 |
Ajith, C; Gupta, S; Kanwar, AJ | 1 |
Freyschmidt-Paul, P; Gupta, P; Hildebrand, D; Hummel, S; Kiessling, S; Marhaba, R; Vitacolonna, M; Zöller, M | 1 |
Baniyash, M; Freyschmidt-Paul, P; Hildebrand, D; Marhaba, R; Vitacolonna, M; Zöller, M | 1 |
Hamasaki, Y; Hatamochi, A; Ikeda, H; Shimaoka, Y; Suzuki, H; Yamazaki, S | 1 |
Mato, F; Miranda, A; Quiñones, PA | 1 |
Giannetti, A; Orecchia, G | 1 |
Case, PC; Ellis, CN; Headington, JT; Mitchell, AJ; Swanson, NA; Vanderveen, EE | 1 |
Fenske, NA; Flowers, FP; Pullara, TJ; Slazinski, L | 1 |
Büchner, U; Echternacht-Happle, K; Göggelmann, W; Happle, R; Kalveram, KJ; Summer, KH | 1 |
Malagoli, P; Orecchia, G | 1 |
Bardazzi, F; Cameli, N; Fanti, PA; Guerra, L; Morelli, R; Tosti, A | 1 |
Malagoli, P; Orecchia, G; Santagostino, L | 1 |
Happle, R; van der Steen, PH | 1 |
Cicero, RL; Innocenzi, D; Micali, G; Nasca, MR | 1 |
Bardazzi, F; Guidetti, MS; Misciali, C; Tosti, A | 1 |
Cicero, RL; Micali, G; Nasca, MR; Sapuppo, A | 1 |
Ang, CB; Chua, SH; Goh, CL | 1 |
Cargnello, S; Frattasio, A; Germino, M; Patrone, P | 1 |
Iijima, S; Otsuka, F | 1 |
Licastro Cicero, R; Micali, G; Nasca, MR; Pulvirenti, N | 1 |
Rokhsar, CK; Shupack, JL; Vafai, JJ; Washenik, K | 1 |
Buckley, DA; du Vivier, AW | 1 |
Boggess, D; Freyschmidt-Paul, P; Happle, R; Hoffmann, R; McElwee, KJ; Metz, S; Sundberg, JP | 1 |
Patrone, P; Stinco, G | 1 |
Freyschmidt-Paul, P; Gardner, S; Happle, R; Hoffmann, R; Lindsey, NJ; Sundberg, JP; Tobin, DJ | 1 |
McMichael, AJ; Pardasani, AG; Turner, E | 1 |
Boezeman, JB; Happle, R; van der Steen, PH | 1 |
Bigardi, A; Pigatto, PD; Rossi, A; Valsecchi, R | 1 |
Bröcker, EB; Hamm, H; John, SM; Steinhausen, D | 1 |
Happle, R; Perret, CM; Steijlen, PM; Zaun, H | 1 |
Cainelli, T; Naldi, L; Parazzini, F | 1 |
Borroni, G; Orecchia, G; Perfetti, L; Rabbiosi, G | 1 |
Marelli, MA; Orecchia, G; Perfetti, L; Rabbiosi, G | 1 |
Cainelli, T; Foiadelli, L; Rossi, A; Valsecchi, R | 1 |
Johansson, E; Kianto, U; Niemi, KM; Ranki, A; Reunala, T | 1 |
Happle, R; Perret, CM; Steijlen, PM | 1 |
Orecchia, G | 2 |
Bardazzi, F; Guerra, L; Tosti, A | 1 |
Gasponi, A; Manuzzi, P; Tosti, A | 1 |
Brasile, GP; Capobianco, C; Guerra, L; Tosti, A | 1 |
Douville, H; Marelli, MA; Orecchia, G; Paulli, M; Rosso, R | 1 |
Capelli, E; Cuccia Belvedere, M; Martinetti, M; Orecchia, G; Rabbiosi, G | 1 |
Caserio, RJ | 1 |
Altomare, GF; Pigatto, PD; Polenghi, MM; Rapisarda, R | 1 |
Sherertz, EF; Sloan, KB | 1 |
Orecchia, G; Rabbiosi, G | 2 |
Bardazzi, F; Ghetti, P; Tosti, A | 1 |
De Padova, MP; Minghetti, G; Tosti, A; Veronesi, S | 1 |
Morishita, M; Nagai, T; Sato, Y | 1 |
Barth, JH; Darley, CR; Gibson, JR | 2 |
Cainelli, T; Panunzio, M; Perego, GB; Rossi, A; Smojver, E; Tornaghi, A; Valsecchi, R | 1 |
Cainelli, T; Valsecchi, R | 1 |
Henkin, J; Smith, RG; Wilkerson, MG; Wilkin, JK | 1 |
10 review(s) available for squaric acid dibutyl ester and Alopecia Circumscripta
Article | Year |
---|---|
Hair Regrowth Outcomes of Contact Immunotherapy for Patients With Alopecia Areata: A Systematic Review and Meta-analysis.
Topics: Adjuvants, Immunologic; Alopecia; Alopecia Areata; Cyclobutanes; Cyclopropanes; Hair; Humans; Immunotherapy; Recurrence | 2018 |
Current treatment of alopecia areata.
Topics: Administration, Cutaneous; Adrenal Cortex Hormones; Alopecia Areata; Anthralin; Cyclobutanes; Cyclopropanes; Cyclosporine; Dermatologic Agents; Humans; Immunosuppressive Agents; Injections, Intralesional; Methotrexate; Minoxidil; PUVA Therapy; Self-Help Groups | 2013 |
Modified immunotherapy for alopecia areata.
Topics: Adjuvants, Immunologic; Alopecia Areata; Autoimmunity; Combined Modality Therapy; Cyclobutanes; Humans; Immunotherapy | 2016 |
Treatment of alopecia areata in children.
Topics: Adjuvants, Immunologic; Administration, Cutaneous; Alopecia Areata; Anthralin; Child; Child, Preschool; Cyclobutanes; Cyclopropanes; Dermatologic Agents; Dinitrochlorobenzene; Glucocorticoids; Humans; Immunosuppressive Agents; Immunotherapy; Minoxidil; Phototherapy; Practice Guidelines as Topic; Treatment Outcome; Vasodilator Agents | 2009 |
Topical sensitizers in alopecia areata.
Topics: Adjuvants, Immunologic; Administration, Cutaneous; Alopecia Areata; Cyclobutanes; Cyclopropanes; Dinitrochlorobenzene; Humans; Inflammation; Irritants; Patient Selection; Prognosis; Severity of Illness Index; Treatment Outcome | 2004 |
Topical immunotherapy in the treatment of chronic severe alopecia areata.
Topics: Administration, Topical; Allergens; Alopecia Areata; Chronic Disease; Cyclobutanes; Cyclopropanes; Dinitrochlorobenzene; Hair; Humans; Immunotherapy | 1993 |
Efficacy of topical sensitizers in the treatment of alopecia areata.
Topics: Adjuvants, Immunologic; Administration, Cutaneous; Alopecia Areata; Cyclobutanes; Cyclopropanes; Hair; Humans; Prognosis; Safety | 1998 |
Topical immunotherapy in dermatology.
Topics: Administration, Topical; Allergens; Alopecia Areata; Cyclobutanes; Cyclopropanes; Decision Making; Dinitrochlorobenzene; Humans; Immunotherapy; Warts | 1999 |
Role of topical immunotherapy in the treatment of alopecia areata. Quality analysis of articles published between January 1977 and January 1988 about three treatments. Reading Group.
Topics: Administration, Cutaneous; Alopecia Areata; Cyclobutanes; Cyclopropanes; Dinitrochlorobenzene; Humans; Immunotherapy; Meta-Analysis as Topic | 1990 |
[Alopecia areata; pathogenesis and topical immunotherapy].
Topics: Allergens; Alopecia Areata; Cyclobutanes; Cyclopropanes; Female; Humans; Male | 1989 |
10 trial(s) available for squaric acid dibutyl ester and Alopecia Circumscripta
Article | Year |
---|---|
Topical immunomodulator therapy with squaric acid dibutylester (SADBE) is effective treatment for severe alopecia areata (AA): results of an open-label, paired-comparison, clinical trial.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Aged; Alopecia Areata; Analysis of Variance; Chi-Square Distribution; Child; Child, Preschool; Cyclobutanes; Female; Humans; Male; Middle Aged; Treatment Outcome | 2005 |
Efficacy and safety of the topical sensitizer squaric acid dibutyl ester in Alopecia areata and factors influencing the outcome.
Topics: Adjuvants, Immunologic; Administration, Cutaneous; Adolescent; Adult; Alopecia Areata; Child; Cyclobutanes; Female; Humans; India; Male; Middle Aged; Severity of Illness Index; Treatment Outcome | 2006 |
Topical squaric acid dibutylester therapy for alopecia areata.
Topics: Administration, Topical; Adolescent; Adult; Aged; Allergens; Alopecia Areata; Child; Clinical Trials as Topic; Cyclobutanes; Dermatitis, Contact; Female; Humans; Male; Middle Aged | 1982 |
Contact allergy as a therapeutic tool for alopecia areata: application of squaric acid dibutylester.
Topics: Adolescent; Adult; Allergens; Alopecia Areata; Animals; Child; Cyclobutanes; Dermatitis, Contact; Dinitrochlorobenzene; Female; Guinea Pigs; Humans; Male; Middle Aged; Mutagens; Time Factors | 1980 |
Topical squaric acid dibutylester therapy for alopecia areata: a double-sided patient-controlled study.
Topics: Administration, Topical; Adolescent; Adult; Allergens; Alopecia Areata; Cyclobutanes; Double-Blind Method; Female; Follow-Up Studies; Hair; Humans; Immunotherapy; Male; Middle Aged; Prospective Studies; Time Factors | 1996 |
Prognostic factors for clinical response of alopecia areata to topical immunotherapy with squaric acid dibutylester.
Topics: Administration, Topical; Adolescent; Adult; Alopecia Areata; Child; Cyclobutanes; Female; Humans; Immunotherapy; Male; Middle Aged; Prognosis | 1997 |
Treatment of alopecia areata with squaric acid dibutylester.
Topics: Allergens; Alopecia Areata; Clinical Trials as Topic; Cyclobutanes; Female; Hair; Humans; Male; Scalp Dermatoses | 1987 |
[Controlled study of the efficacy of topical immunotherapy in alopecia areata: squaric acid versus placebo].
Topics: Administration, Topical; Adolescent; Adult; Allergens; Alopecia Areata; Clinical Trials as Topic; Cyclobutanes; Drug Evaluation; Female; Humans; Male | 1987 |
Therapies versus placebo in the treatment of patchy alopecia areata.
Topics: Adolescent; Adult; Age Factors; Aged; Alopecia Areata; Child; Child, Preschool; Clinical Trials as Topic; Cyclobutanes; Cyclopropanes; Female; Humans; Male; Middle Aged; Minoxidil; Placebos | 1986 |
Squaric acid dibutyl ester in the treatment of alopecia areata.
Topics: Adolescent; Adult; Alopecia Areata; Child; Clinical Trials as Topic; Cyclobutanes; Female; Humans; Male; Middle Aged | 1985 |
60 other study(ies) available for squaric acid dibutyl ester and Alopecia Circumscripta
Article | Year |
---|---|
Squaric acid dibutyl ester for the treatment of alopecia areata: A retrospective evaluation.
Topics: Adult; Alopecia; Alopecia Areata; Cyclobutanes; Female; Humans; Immunotherapy; Male; Retrospective Studies | 2021 |
Iatrogenic cutaneous lymphoid hyperplasia induced by squaric acid dibutyl ester.
Topics: Administration, Cutaneous; Allergens; Alopecia Areata; Cyclobutanes; Dermatitis, Allergic Contact; Humans; Hyperplasia; Iatrogenic Disease; Male; Middle Aged | 2021 |
Therapeutic approach with squaric acid dibutylester for steroid resistant-alopecia areata incognita: A pilot study of a single center.
Topics: Alopecia Areata; Cyclobutanes; Female; Humans; Pilot Projects; Steroids | 2021 |
Immunotherapy for resistant and/or severe alopecia areata in a university hospital setting in Northern Mexico.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Alopecia Areata; Child; Child, Preschool; Cyclobutanes; Cyclopropanes; Female; Hospitals, University; Humans; Immunotherapy; Male; Mexico; Middle Aged; Retrospective Studies; Young Adult | 2020 |
Hapten-induced lymphadenosis benigna cutis secondary to squaric acid dibutylester sensitization for alopecia areata.
Topics: Adult; Alopecia Areata; Choristoma; Cyclobutanes; Female; Haptens; Humans; Immunotherapy; Skin Diseases | 2014 |
Effective squaric acid dibutylester immunotherapy is associated with a reduction of skin infiltrating T-helper (Th)1 and Th17 cells in alopecia areata patients.
Topics: Adjuvants, Immunologic; Alopecia Areata; Cyclobutanes; Humans; Immunotherapy; Prospective Studies; Th1 Cells; Th17 Cells | 2015 |
Squaric acid sensitization is not required for response in the treatment of alopecia areata.
Topics: Administration, Topical; Adolescent; Adrenal Cortex Hormones; Adult; Alopecia Areata; Child; Child, Preschool; Cyclobutanes; Female; Follow-Up Studies; Hair; Humans; Immunization; Male; Retrospective Studies; Risk Assessment; Sampling Studies; Treatment Outcome; Young Adult | 2015 |
Childhood epidermolysis bullosa acquisita during squaric acid dibutyl ester immunotherapy for alopecia areata.
Topics: Alopecia Areata; Child; Cyclobutanes; Dermatologic Agents; Epidermolysis Bullosa Acquisita; Humans; Immunotherapy; Male | 2017 |
Angioedema After Squaric Acid Treatment in a 6-Year-Old Girl.
Topics: Adjuvants, Immunologic; Allergens; Alopecia Areata; Angioedema; Child; Cyclobutanes; Female; Humans | 2017 |
Fexofenadine hydrochloride enhances the efficacy of contact immunotherapy for extensive alopecia areata: Retrospective analysis of 121 cases.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Aged; Alopecia Areata; Child; Child, Preschool; Cyclobutanes; Cyclopropanes; Dermatologic Agents; Female; Humans; Hypersensitivity; Immunotherapy; Male; Middle Aged; Retrospective Studies; Terfenadine; Young Adult | 2009 |
Delayed type hypersensitivity-induced myeloid-derived suppressor cells regulate autoreactive T cells.
Topics: Adaptor Proteins, Signal Transducing; Alopecia Areata; Animals; Apoptosis; Autoimmune Diseases; Autoimmunity; CD4-CD8 Ratio; Cell Differentiation; Cell Proliferation; Cells, Cultured; Cyclobutanes; Hypersensitivity, Delayed; Lymphocyte Activation; Mice; Mice, Inbred C3H; Mitochondria; Myeloid Cells; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Receptors, Antigen, T-Cell; Receptors, Tumor Necrosis Factor; Signal Transduction; T-Lymphocytes; Tretinoin; Tumor Necrosis Factor-alpha | 2011 |
Alopecia areata triggered or exacerbated by swine flu virus infection.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Alopecia Areata; Antiviral Agents; Child; Child, Preschool; Cyclobutanes; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Zanamivir | 2012 |
Seventeen cases of alopecia areata: combination of SADBE topical immunotherapy with other therapies.
Topics: Adjuvants, Immunologic; Administration, Oral; Administration, Topical; Adolescent; Adult; Alkaloids; Alopecia Areata; Benzylisoquinolines; Child; Combined Modality Therapy; Cryotherapy; Cyclobutanes; Female; gamma-Aminobutyric Acid; Humans; Immunotherapy; Male; Middle Aged | 2002 |
The pattern and profile of alopecia areata in Singapore--a study of 219 Asians.
Topics: Adjuvants, Immunologic; Adolescent; Adrenal Cortex Hormones; Adult; Age Factors; Aged; Aged, 80 and over; Allergens; Alopecia Areata; Child; Child, Preschool; Cohort Studies; Cyclobutanes; Dermatitis, Atopic; Female; Humans; Immunotherapy; Incidence; Infant; Male; Middle Aged; Nail Diseases; Singapore; Surveys and Questionnaires | 2002 |
Lentiginous eruption due to topical immunotherapy.
Topics: Adjuvants, Immunologic; Adolescent; Alopecia Areata; Cyclobutanes; Drug Eruptions; Humans; Lentigo; Male; Melanocytes | 2003 |
Chronic delayed-type hypersensitivity reaction as a means to treat alopecia areata.
Topics: Allergens; Alopecia Areata; Animals; Autoimmune Diseases; Cells, Cultured; Cyclobutanes; Hypersensitivity, Delayed; Immunophenotyping; Immunotherapy; Leukocytes; Lymph Nodes; Mice; Mice, Inbred C3H; Skin; T-Lymphocyte Subsets | 2004 |
Prolonged dermatitis distant to the site of squaric acid dibutyl ester applications and recovery of alopecia areata.
Topics: Administration, Cutaneous; Adult; Alopecia Areata; Cyclobutanes; Drug Eruptions; Female; Humans | 2005 |
A chronic contact eczema impedes migration of antigen-presenting cells in alopecia areata.
Topics: Alopecia Areata; Animals; Antigen-Presenting Cells; Cell Adhesion Molecules; Cell Movement; Chemokines; Chronic Disease; Cyclobutanes; Dendritic Cells, Follicular; Dermatitis, Contact; Female; Gene Expression Regulation; Hair Follicle; Leukocytes; Lymph Nodes; Mice; Mice, Inbred C3H; Receptors, Chemokine; Skin; T-Lymphocytes | 2006 |
The importance of myeloid-derived suppressor cells in the regulation of autoimmune effector cells by a chronic contact eczema.
Topics: Allergens; Alopecia Areata; Animals; Autoimmune Diseases; Chronic Disease; Cyclobutanes; Dermatitis, Contact; Down-Regulation; Hypersensitivity, Delayed; Membrane Proteins; Mice; Mice, Inbred C3H; Myeloid Cells; Receptors, Antigen, T-Cell; T-Lymphocytes, Regulatory | 2007 |
Discoid lupus erythematosus exacerbated by contact dermatitis caused by use of squaric acid dibutylester for topical immunotherapy in a patient with alopecia areata.
Topics: Adjuvants, Immunologic; Administration, Topical; Alopecia Areata; Cyclobutanes; Dermatitis, Contact; Humans; Lupus Erythematosus, Discoid; Male; Middle Aged | 2008 |
[Squaric acid dibutyl ester in the treatment of severe alopecia areata].
Topics: Adjuvants, Immunologic; Adolescent; Adult; Alopecia Areata; Chemical Phenomena; Chemistry; Child; Child, Preschool; Cyclobutanes; Drug Evaluation; Female; Humans; Lymphatic Diseases; Male; Pigmentation Disorders | 1984 |
Clinical experience on the treatment of alopecia areata with squaric acid dibutyl ester.
Topics: Adolescent; Adult; Allergens; Alopecia Areata; Child; Cyclobutanes; Female; Humans; Male; Middle Aged | 1983 |
Topical therapy of alopecia areata with squaric acid dibutylester.
Topics: Administration, Topical; Adult; Allergens; Alopecia Areata; Cyclobutanes; Dinitrochlorobenzene; Female; Humans; Immunotherapy; Male | 1984 |
Topical immunotherapy in children with alopecia areata.
Topics: Administration, Topical; Adolescent; Allergens; Alopecia Areata; Child; Cyclobutanes; Follow-Up Studies; Humans; Immunotherapy; Recurrence; Remission Induction | 1995 |
Alopecia areata. A pathological study of nonresponder patients.
Topics: Adolescent; Adult; Alopecia Areata; Child; Cyclobutanes; Drug Resistance; Female; Humans; Male; Middle Aged; Skin | 1994 |
Treatment of severe alopecia areata with squaric acid dibutylester in pediatric patients.
Topics: Administration, Cutaneous; Adolescent; Alopecia Areata; Child; Child, Preschool; Cyclobutanes; Female; Follow-Up Studies; Hair; Humans; Lymphatic Diseases; Male; Recurrence | 1994 |
Topical immunotherapy of alopecia areata.
Topics: Administration, Topical; Allergens; Alopecia Areata; Cyclobutanes; Cyclopropanes; Hair; Humans; Immunotherapy | 1993 |
Persistent allergic contact dermatitis at the site of primary sensitization with squaric acid dibutyl ester.
Topics: Adult; Allergens; Alopecia Areata; Cyclobutanes; Dermatitis, Allergic Contact; Female; Humans; Immunization; Immunotherapy | 1995 |
Long-term results of topical immunotherapy in children with alopecia totalis or alopecia universalis.
Topics: Administration, Cutaneous; Adolescent; Allergens; Alopecia Areata; Autoantibodies; Child; Cyclobutanes; Female; Follow-Up Studies; Hair; Humans; Immunotherapy; Male; Recurrence; Treatment Outcome | 1996 |
Treatment of alopecia areata with squaric acid dibutylester.
Topics: Adolescent; Adult; Allergens; Alopecia Areata; Child; Child, Preschool; Cyclobutanes; Dermatologic Agents; Female; Follow-Up Studies; Hair; Humans; Male; Middle Aged; Treatment Failure; Treatment Outcome | 1996 |
Side-effects during treatment with SADBE.
Topics: Adult; Allergens; Alopecia Areata; Cyclobutanes; Dermatitis, Allergic Contact; Drug Eruptions; Humans; Male; Patch Tests | 1997 |
Transient leucoderma appearing in an untreated area following contact immunotherapy for alopecia areata.
Topics: Adolescent; Alopecia Areata; Cyclobutanes; Female; Forehead; Humans; Hypopigmentation; Immunotherapy; Remission, Spontaneous | 1998 |
Successful treatment of alopecia areata-like hair loss with the contact sensitizer squaric acid dibutylester (SADBE) in C3H/HeJ mice.
Topics: Allergens; Alopecia Areata; Animals; CD4-CD8 Ratio; Cyclobutanes; Dermis; Epithelium; Female; Hair; Hair Follicle; Histocompatibility Antigens Class I; Histocompatibility Antigens Class II; Intercellular Adhesion Molecule-1; Lymphocytes; Male; Mice; Mice, Inbred C3H; Sebaceous Glands; Skin; Treatment Outcome | 1999 |
Questions raised by skin reactions observed during squaric acid dibutyl ester contact sensitization.
Topics: Adjuvants, Immunologic; Allergens; Alopecia Areata; Cyclobutanes; Dermatitis, Allergic Contact; Diagnosis, Differential; Female; Forearm; Humans; Middle Aged; Patch Tests | 2000 |
Normalisation of hair follicle morphology in C3H/HeJ alopecia areata mice after treatment with squaric acid dibutylester.
Topics: Adjuvants, Immunologic; Alopecia Areata; Animals; Cyclobutanes; Female; Hair; Hair Color; Hair Follicle; Male; Mice; Mice, Inbred C3H; Microscopy, Electron | 2000 |
Squaric acid dibutylester: indications for use and efficacy in alopecia areata.
Topics: Administration, Topical; Adolescent; Adult; Age Distribution; Alopecia Areata; Autoimmune Diseases; Child; Cyclobutanes; Demography; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Retrospective Studies; Sample Size; Sex Distribution; Treatment Outcome | 2001 |
Topical immunotherapy for alopecia areata: re-evaluation of 139 cases after an additional follow-up period of 19 months.
Topics: Administration, Topical; Alopecia Areata; Cyclobutanes; Cyclopropanes; Follow-Up Studies; Humans; Immunotherapy; Male; Prognosis | 1992 |
The loss of contact sensitization in man.
Topics: Administration, Topical; Adolescent; Adult; Aged; Alopecia Areata; Child; Cyclobutanes; Dermatitis, Contact; Dinitrochlorobenzene; Female; Follow-Up Studies; Humans; Male; Middle Aged; Patch Tests | 1991 |
Topical immunotherapy with contact allergens in alopecia areata: evidence for non-specific systemic suppression of cellular immune reactions.
Topics: Administration, Cutaneous; Adolescent; Adult; Allergens; Alopecia Areata; Cyclobutanes; Cyclopropanes; Female; Humans; Hypersensitivity, Delayed; Immunity, Cellular; Immunotherapy; Male; Middle Aged | 1991 |
Erythema multiforme-like eruptions: a rare side effect of topical immunotherapy with diphenylcyclopropenone.
Topics: Administration, Topical; Adult; Alopecia Areata; Cyclobutanes; Cyclopropanes; Drug Eruptions; Erythema Multiforme; Female; Humans; Middle Aged | 1990 |
Photochemotherapy plus squaric acid dibutylester in alopecia areata treatment.
Topics: Adult; Alopecia Areata; Cyclobutanes; Female; Humans; Middle Aged; PUVA Therapy | 1990 |
Alopecia areata: more on topical sensitizers.
Topics: Administration, Topical; Alopecia Areata; Cyclobutanes; Female; Humans; Prognosis; Psoriasis | 1990 |
Topical immunotherapy of alopecia areata. A follow-up study.
Topics: Administration, Topical; Adolescent; Adult; Alopecia Areata; Child; Cyclobutanes; Dinitrochlorobenzene; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nitrobenzenes; Recurrence | 1986 |
Immunohistological evaluation of alopecia areata treated with squaric acid dibutylester (SADBE).
Topics: Adolescent; Adult; Alopecia Areata; B-Lymphocytes; Complement C3; Cyclobutanes; Female; Fibrin; Fluorescent Antibody Technique; Humans; Immunoglobulins; Male; Middle Aged; T-Lymphocytes | 1986 |
Thymopentin in the treatment of alopecia areata.
Topics: Adjuvants, Immunologic; Alopecia Areata; Cyclobutanes; Drug Therapy, Combination; Humans; Injections, Intradermal; Injections, Intravenous; Peptide Fragments; Thymopentin; Thymopoietins; Thymus Hormones | 1989 |
Contact urticaria during topical immunotherapy.
Topics: Administration, Topical; Adult; Alopecia Areata; Cyclobutanes; Cyclopropanes; Dermatitis, Contact; Dinitrochlorobenzene; Female; Humans; Immunotherapy; Male; Urticaria | 1989 |
Thymopentin in the treatment of severe alopecia areata.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Alopecia Areata; Cyclobutanes; Cyclopropanes; Female; Humans; Male; Middle Aged; Peptide Fragments; Thymopentin; Thymopoietins; Thymus Hormones | 1988 |
[Sensitization therapy in severe alopecia areata].
Topics: Adolescent; Adult; Aged; Allergens; Alopecia Areata; Child; Child, Preschool; Cyclobutanes; Cyclopropanes; Female; Humans; Immunization; Male; Middle Aged | 1988 |
[In situ lymphocyte subpopulation in alopecia areata after treatment with squaric acid dibutyl ester].
Topics: Adolescent; Adult; Allergens; Alopecia Areata; Child; Cyclobutanes; Female; Humans; Lymphocytes; Male; Middle Aged; Time Factors | 1988 |
Decreased in vitro lymphocyte stimulation and reduced sensitivity to IL-2 in patients with alopecia areata.
Topics: Administration, Cutaneous; Adolescent; Adult; Alopecia Areata; Child; Concanavalin A; Cyclobutanes; HLA-DR Antigens; Humans; In Vitro Techniques; Interleukin-2; Lymphocyte Activation; Middle Aged; Phytohemagglutinins | 1988 |
Percutaneous penetration of squaric acid and its esters in hairless mouse and human skin in vitro.
Topics: Allergens; Alopecia Areata; Animals; Cyclobutanes; Female; Humans; In Vitro Techniques; Mice; Mice, Hairless; Skin | 1988 |
Patterns of hair regrowth in alopecia areata.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Alopecia Areata; Child; Cyclobutanes; Cyclopropanes; Female; Hair; Humans; Male; Minoxidil | 1988 |
Unusual complication of sensitizing therapy for alopecia areata.
Topics: Acetone; Adult; Alopecia Areata; Cyclobutanes; Dermatitis, Contact; Female; Humans | 1988 |
Squaric acid dibutylester in alopecia areata: is discomfort really necessary?
Topics: Alopecia Areata; Cyclobutanes; Humans | 1987 |
[Topical therapy of alopecia areata with squaric acid dibutyl ester].
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Alopecia Areata; Child; Child, Preschool; Cyclobutanes; Drug Evaluation; Female; Humans; Infant; Male; Middle Aged | 1987 |
Alopecia areata and measles.
Topics: Alopecia Areata; Child; Cyclobutanes; Hair; Humans; Male; Measles | 1987 |
Squaric acid esters in the treatment of alopecia areata.
Topics: Allergens; Alopecia Areata; Cyclobutanes; Humans | 1986 |
Squaric acid dibutylester treatment of alopecia areata.
Topics: Adolescent; Adult; Alopecia Areata; Child; Child, Preschool; Cyclobutanes; Dermatitis, Contact; Female; Humans; Male; Middle Aged | 1985 |
Nickel sensitivity as a complication of squaric acid dibutylester treatment of alopecia areata.
Topics: Adult; Allergens; Alopecia Areata; Cyclobutanes; Dermatitis, Contact; Female; Humans; Nickel | 1985 |
Squaric acid and esters: analysis for contaminants and stability in solvents.
Topics: Alopecia; Alopecia Areata; Butadienes; Carcinogens; Cyclobutanes; Gas Chromatography-Mass Spectrometry; Humans; Hydrolysis | 1985 |